01 - 03 September, 2020
Nice Acropolis | Nice, France
Conference Day Three - 3 September 2020
8:15 am - 8:50 am Welcome coffee
IGNITING YOUR SUPPLY CHAIN OF THE FUTURE
8:50 am - 9:00 am Chairman’s opening address
9:00 am - 9:20 am KEYNOTE CASE STUDY – How to ensure customer-centricity lies at the heart of your global supply chain strategy
- Why should customer centricity be at the top of the agenda for every pharma producer in the industry?
- What key strategic shifts are taking place at a major producer in order to assure this customer centricity?
- Case study of how a leading pharmaceutical producer has ensured significantly greater customer service through a process of segmentation
- What will future product portfolios demand and new technologies enable around the development of customer-centric operations?
9:20 am - 9:40 am KEYNOTE CASE STUDY - The Connected Channel: How to use blockchain to integrate with partners and achieve true optimised end to end supply chains
- Case study of the world’s first commercial scale blockchain implementation in pharma supply chain
- How is the technology being used to implement far more effective traceability in the end to end supply chain
- What is required in order to effectively scale up from the pilot projects and clinical trials scale implementation?
- What are the benefits of pan industry producer alliances for the adoption of the technology?
Paolo MigliariExec. Director Supply Excellence
David RuizGlobal Demand and Customer Integration Lead
9:40 am - 10:20 am PANEL DISCUSSION- How can you best collaborate to aggregate volume, drive economies of scale and enable significant developments in sea freight operations?
- What are the largest barriers for the adoption of sea freight in pharmaceutical logistics?
- What are key stakeholders doing across the end to end supply chain in order to drive the viability of sea freight?
- What remains to be done and why is collaboration of huge importance?
Torben WeilmuensterHead of Global Supply Chain Management
Isabelle ConrotHead of Global Supply Chain Operations
10:20 am - 10:40 am CASE STUDY – How to improve on visibility, cost and feasibility of global sea freight operations in pharma
- An update on groundbreaking activities being developed within sea freight operations for pharma
- How are several key stakeholders working together in order to actualize these operations on a global scale?
- What are the greatest ongoing challenges to the project and to industry wide adoption?
- How are these challenges being overcome and what lessons have been learnt form the project?
10:40 am - 11:20 am KEYNOTE PRESENTATION – How to strategise for and implement data driven end to end supply chain operations on a global scale
- What is meant by ‘data driven operations’ and what are the most significant benefits to the organisation?
- What is required from top level management to embrace and implement and data driven operations?
- Lessons learnt and best practice derived from at scale implementation from one of the largest producers in the world
Marc MolinaroHead IT Supply Chain and Technical Operations Strategy
11:20 am - 12:00 pm Morning networking break
11:20 am - 12:10 pm MASTERCLASS (50 mins)
11:20 am - 12:10 pm MASTERCLASS (50 mins)
TRACK A - Strengthening Not-For Profit and Emerging Market Opportunities12:00 pm - 12:20 pm CASE STUDY – Update from The Global Fund: How is supply chain playing the pivotal role in the world’s fight against tuberculosis, AIDS and malaria?
TRACK A - Strengthening Not-For Profit and Emerging Market Opportunities12:20 pm - 12:40 pm CASE STUDY - How to develop blockchain solutions from proof-of-concept through to at-scale use in pharma supply to tackle reproducibility, data sharing, traceability and privacy challenges
TRACK A - Strengthening Not-For Profit and Emerging Market Opportunities12:40 pm - 1:00 pm CASE STUDY – What are the greatest GDP challenges that arose from vaccine distribution and supply chain activities during the ebola crisis, and how was these best managed?
TRACK A - Strengthening Not-For Profit and Emerging Market Opportunities1:00 pm - 1:20 pm CASE STUDY - How can pharma producers of all sizes drive their not for profit activities through supply chain and achieve greater corporate social responsibility in the process?
TRACK B - Mastering Temperature Control & Logistics12:00 pm - 12:40 pm CASE STUDY INTERACTIVE – How are temperature controlled logistics networks developing in step to meet the significant requirements cell gene therapies?
TRACK B - Mastering Temperature Control & Logistics12:40 pm - 1:20 pm PANEL DISCUSSION – Exploiting multi-modal: How can you best deliver best practice network design for temperature controlled logistics on a global scale?
TRACK C – Interactive Workshop12:00 pm - 1:20 pm COLLABORATIVE WORKING GROUP - Crossing the Chasm: How to develop a systematic approach for supply chain and logistics scale up
1:20 pm - 2:00 pm Networking Lunch
Track A - Catalysing Innovation In End To End Supply Chains2:00 pm - 2:30 pm OXFORD STYLE DEBATE – FOR and AGAINST: Drones delivery in pharmaceutical logistics is no longer a fringe technology
FOR – The use of drones is a highly versatile technology that is a viable logistics tool for a range of pharma distribution activities
AGAINST – Drones are still in the hype phase, and with the exception of a small number of use cases should not be considered as a viable operational tool
Emre GolluSenior Supply Chain Manager
Track A - Catalysing Innovation In End To End Supply Chains2:30 pm - 3:10 pm PANEL DISCUSSION - How can the industry collaborate to drive diversity, inclusion in the pharma supply chain?
- Incorporating the viewpoints of a range of key stakeholders in pharma supply chain
- What initiatives are taking place within big pharma around diversity, inclusion and equal opportunity?
- What effects can this have upon talent pool and business results?
- What opportunities for collaboration across producers and other stakeholders exist that help to promote this?
Alvine TremouletEU Head of Diversity & Inclusion
Debbie FrancisSupply Chain Lead
Track A - Catalysing Innovation In End To End Supply Chains3:10 pm - 3:30 pm FIRESIDE CHAT – What has the industry learnt from planning and operations associated with the political and commercial instability of Brexit?
- What has the impact of Brexit been upon a range of producers and how did they choose to try and mitigate the risks associated with Brexit?
- What would key players in the industry have done differently, were they to be given the opportunity (drawing lessons learnt)?
- What have producers learnt that they can apply to future situations (drawing best practice)?
- What near future geo-political risks do you see to the global pharma supply chain and why?
Caroline PanahDirector Manufacturing & Supply Chain Strategy
Karin JavelleDirector Supply Chain Planning
Track B - Pharma Supply Chain Dragons Den2:00 pm - 2:30 pm COLLABORATIVE WORKING GROUP - What is the future of direct to patient and eCommerce for pharma and what must you do now to remain relevant into the future?
Track B - Pharma Supply Chain Dragons Den2:30 pm - 3:30 pm Examining the latest and greatest industry innovations - Which offer true added value and should be considered in your future supply chain transformation plans?
Join our dragons during this exciting ‘Dragons Den’ style session, where you will hear from four new and innovative start-up technology firms as they present their offerings in a bid to win first place. Listen up as the dragons’ review the technologies’ benefits to your business, predict their future success and deliver their verdicts. The ultimate decision is in your hands though, as the audience get to vote for their favorite.